Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells Jing ZouPing ZouLingbo Liu Original Article 19 January 2012 Pages: 813 - 823
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups Marysia HengeveldStefan SuciuTheo de Witte Original Article Open access 31 March 2012 Pages: 825 - 835
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group Xiaoyang LiZhao LiuZhixiang Shen Original Article 09 December 2011 Pages: 837 - 845
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma Grit HutterMalte RiekenMartin Dreyling Original Article 11 January 2012 Pages: 847 - 856
High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease Xiang-Gui YuanFei-Fei ChenJie Jin Original Article 22 December 2011 Pages: 857 - 861
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course Natalie PutKatrien Van Roosbroeckon behalf of the BCGHo and the GFCH Original Article 30 December 2011 Pages: 863 - 873
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma Giovanni BarosiGiampaolo MerliniSante Tura Original Article 04 April 2012 Pages: 875 - 888
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment Moo-Kon SongJoo-Seop ChungKorean Multiple Myeloma Working Party Original Article 13 January 2012 Pages: 889 - 896
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors Han-Seung ParkDae-Young KimKyoo-Hyung Lee Original Article 08 December 2011 Pages: 897 - 904
A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study Paolo RicchiMassimiliano AmmirabileLuciano Prossomariti Original Article 15 December 2011 Pages: 905 - 909
Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women Florence MasaisaCandace BremanJan Philippé Original Article 17 January 2012 Pages: 911 - 916
A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers Vivian LoboShrimati ShettyKanjaksha Ghosh Original Article 21 December 2011 Pages: 917 - 921
Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting Edgar FaberDavid FriedeckýTomáš Adam Original Article 11 January 2012 Pages: 923 - 929
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study Luigi RigacciBendetta PucciniGruppo Italiano Trapianto di Midollo Osseo (GITMO) Original Article 14 January 2012 Pages: 931 - 939
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia Anna Paola IoriVeronica ValleRoberto Foà Original Article 03 January 2012 Pages: 941 - 948
Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children T. FazekasN. PrucknerC. Peters Original Article 12 January 2012 Pages: 949 - 956
Anemia and global iron fortification and supplementation Andrew J. Ghio Letter to the Editor 22 September 2011 Pages: 957 - 958
Targeted (not global) iron supplementation/fortification is the issue! Nils Milman Letter to the Editor 08 September 2011 Pages: 959 - 960
Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values Agustin CastiellaJose M. AlustizaAlazne Aguirre Letter to the Editor 05 October 2011 Pages: 961 - 961
Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies Karen M. K. De VooghtAyşe Y. DemirHans Kemperman Letter to the Editor Open access 06 October 2011 Pages: 963 - 964
Follicular lymphoma with prominent fibrosis complicated by peripheral eosinophilia Rie TabataChiharu TabataRyoji Yasumizu Letter to the Editor 22 September 2011 Pages: 965 - 967
Secondary haematological malignancies after radioimmunotherapy Federica GigliAngelo GardelliniGiovanni Martinelli Letter to the Editor 11 October 2011 Pages: 969 - 969
Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia Larry C. BaconMichael J. BarnettYasser R. Abou Mourad Letter to the Editor 06 October 2011 Pages: 971 - 972
Extensive bone marrow amyloidosis Stefano Licci Letter to the Editor 18 October 2011 Pages: 973 - 974
Lessons from an incidental diagnosis of paroxysmal nocturnal haemoglobinuria Jecko ThachilTim WebsterAnita Hill Letter to the Editor 19 November 2011 Pages: 975 - 976
Genomic analysis of a four-way t(4;11;22;10) associated with MLL-AF4 in an adult acute lymphoblastic leukemia Sun Young ChoTae Sung ParkClaus Meyer Letter to the Editor 17 November 2011 Pages: 977 - 979
